Glaxo Group Limited v. Hareshbhai Natvarbhai Bhesania and Ors.
Case brief
What is this about?
Glaxo Group Limited v. Hareshbhai Natvarbhai Bhesania and others; Lanoxx Pharmaceuticals; LANOXIN; LANIXIME; LANOXX device; trade mark dispute resolved by consent/settlement decree; permanent injunction decree (prayer clauses 60(a)-(d)); amendment of trading name; withdrawal of trademark applications 6246436 and 6246434; costs Rs. 2 Lakhs with staged payment and 9% p.a. default interest; refund of entire court fees under Section 16 Court Fees Act 1870; Delhi High Court commercial division; order dated 19.02.2025; Amit Bansal J.
What did the court decide?
Suit decreed in favour of the plaintiff on the defendants' settlement terms: decree of permanent injunction in terms of prayer clauses 60 (a)-(d); amendment of the defendants' trading name 'Lanoxx Pharmaceuticals' so as not to be similar to 'LANOXIN' (prayer clause 60 (e)); withdrawal of trademark applications nos. 6246436 and 6246434 (prayer clause 60 (f)); costs of Rs. 2 Lakhs (₹1 Lakh within two weeks, balance ₹1 Lakh by 15th May, 2025, failing which interest @ 9% p.a.); certificate of refund of entire Court Fees under Section 16 of the Court Fees Act, 1870; pending applications disposed of; decree sheet to be drawn up.